The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date)

Abstract Triple-negative breast cancer (TNBC) is characterised by the lack or low expression of estrogen, progesterone, and human epidermal growth factor receptor 2 receptors. TNBC has a high recurrence rate, swiftly metastasizes, and has a high mortality rate. Subsequently, the increase in cases of...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Tanaka Ndongwe, Angel-Alberta Zhou, Nelisa Paidamwoyo Ganga, Nyaradzo Matawo, Unami Sibanda, Tinotenda Vanessa Chidziwa, Bwalya A. Witika, Rui W. M. Krause, Gauta Gold Matlou, Xavier Siwe-Noundou
Format:	Artigo
Sprog:	Inglês
Udgivet:	Springer 2024-09-01
Serier:	Discover Nano
Fag:	Triple negative breast cancer Nanomaterials Drug delivery systems
Online adgang:	https://doi.org/10.1186/s11671-024-04089-3
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!